May 22, 2022 7:03 AM
Latest:
  • Biotech Firm OKYO Pharma Closes US$2.5 Million IPO
  • Canaccord Lowers Cresco Labs’ Price Target To $9.50
  • What’s Going On With Aurcana Silver?
  • Ekos Poll: Justin Trudeau Losing Support From Canadians Under 50
  • Crypto Crash, Pierre Poilievre, and the Madonna NFT Snatch
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Healthcare
      • Ayurcann Holdings
      • Bright Minds Biosciences
      • Ketamine One
      • Revive Therapeutics
      • VentriPoint Diagnostics
    • Resources
      • Carbon Streaming Corp
      • Denarius Silver
      • Freeman Gold
      • Gold Mountain Mining
      • Newlox Gold Ventures
      • Nickel 28 Capital
      • Riverside Resources
      • Trillium Gold
    • Technology
      • Datametrex AI Limited
      • EnerDynamic Hybrid Tech
      • Leveljump Healthcare
      • MustGrow Biologics
      • PowerBand Solutions
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Mind Medicine

Briefing Psychedelics 

Mind Medicine To Raise Up To $100 Million Via ATM Financing

May 17, 2022 4:59 PMMay 17, 2022 4:59 PM Jay Lutz 0 Comments ATM Financing, Mind Medicine

Mind Medicine (NEO: MMED) last night announced that it will be conducting a financing. The company is looking to raise

Share
Tweet
Share
Read more
Biotech Briefing 

MindMed Presents Positive Data Studying LSD In Treating Anxiety Disorders

May 11, 2022 10:27 AMMay 11, 2022 10:28 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced today that its top collaborators have released positive topline

Share
Tweet
Share
Read more
Biotech Briefing 

MindMed Declares US$93.0 Million Net Loss, US$133.5 Million Cash Balance For 2021

March 28, 2022 10:14 AMMarch 28, 2022 9:48 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced this morning its financial results for 2021. The biotech

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine CFO Quits Ahead Of Release Of 2021 Financial Results

March 28, 2022 6:45 AMMarch 27, 2022 11:20 PM Jay Lutz 0 Comments Mind Medicine, MindMed

It’s always a positive sign when a chief financial officer resigns the last business day before annual filings are to

Share
Tweet
Share
Read more
Briefing Healthcare Psychedelics 

Mind Medicine Sees Final Co-Founder Leave The Company

January 9, 2022 3:07 PMJanuary 9, 2022 10:08 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) appears to now be fully under new management. On Friday evening, after the close of markets,

Share
Tweet
Share
Read more
Biotech Briefing Psychedelics 

MindMed Concludes Phase 1 Clinical Trial Of Psychedelic Derivative Drug For Opioid Use Disorder

January 4, 2022 10:29 AMJanuary 4, 2022 9:45 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, has recently concluded the phase 1 clinical trial for its

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Closes The Year Out With Further Management Departures

December 29, 2021 8:38 AMDecember 29, 2021 8:38 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) has seen further management departures, following the departure of its CEO this past summer. Classified as

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mind Medicine Sees FDA Place Clinical Hold On Phase 2b Study

December 21, 2021 8:22 AMDecember 21, 2021 8:24 AM Jay Lutz 0 Comments Mind Medicine, MindMed

Mind Medicine (NEO: MMED) this morning indicated that things are not going quite to plan with an IND submission for

Share
Tweet
Share
Read more
Biotech Briefing 

MindMed Launches R(-)-MDMA Program For Autism Spectrum Disorder Symptoms

October 26, 2021 10:35 AMOctober 26, 2021 9:30 AM ER Velasco 0 Comments Mind Medicine, MindMed

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, recently launched a program to develop R(-)-MDMA for treating symptoms

Share
Tweet
Share
Read more
Briefing Psychedelics 

Mindmed: Eight Capital Resumes Coverage With $6.50 Price Target

September 17, 2021 3:23 PMSeptember 16, 2021 10:24 PM Justin Young 0 Comments Analyst Estimate, Mind Medicine

Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Biotech Firm OKYO Pharma Closes US$2.5 Million IPO
Biotech Briefing 

Biotech Firm OKYO Pharma Closes US$2.5 Million IPO

May 21, 2022 5:12 PM ER Velasco 0

Biotech firm OKYO Pharma Limited (Nasdaq: OKYO) closed on Thursday its initial public offering on the Nasdaq Capital Market. The

Canaccord Lowers Cresco Labs’ Price Target To $9.50
Briefing Cannabis 

Canaccord Lowers Cresco Labs’ Price Target To $9.50

May 21, 2022 3:02 PM Justin Young 0
What’s Going On With Aurcana Silver?
Briefing Full Analysis Resources 

What’s Going On With Aurcana Silver?

May 21, 2022 1:10 PM ER Velasco 0
Ekos Poll: Justin Trudeau Losing Support From Canadians Under 50
Briefing Macro 

Ekos Poll: Justin Trudeau Losing Support From Canadians Under 50

May 21, 2022 11:05 AM Hermina Paull 0
Crypto Crash, Pierre Poilievre, and the Madonna NFT Snatch
Blockchain Briefing Full Analysis Macro 

Crypto Crash, Pierre Poilievre, and the Madonna NFT Snatch

May 21, 2022 9:00 AM Braden Maccke 2
Cineplex: Canaccord Lifts Price Target To $18 On Improving Outlook
Briefing Entertainment 

Cineplex: Canaccord Lifts Price Target To $18 On Improving Outlook

May 20, 2022 4:07 PM Justin Young 0
Justin Trudeau to Ban Huawei from Canada’s 5G Networks
Briefing Technology 

Justin Trudeau to Ban Huawei from Canada’s 5G Networks

May 20, 2022 3:13 PM Hermina Paull 0

Spotlight Series

How Does Gaming Evolve From Here? – The Daily Dive
Briefing Esports Technology Video Series 

How Does Gaming Evolve From Here? – The Daily Dive

May 19, 2022 1:30 PM Jay Lutz 0

Today on The Daily Dive, we see the return on Vijai Karthigesu, founder and CEO of Swarmio Media (CSE: SWRM).

News

NG Energy Closes Prospectus Offering For Proceeds Of $17.0 Million
Briefing Energy News 

NG Energy Closes Prospectus Offering For Proceeds Of $17.0 Million

May 20, 2022 2:25 PM Jay Lutz 0

NG Energy (TSXV: GASX) today announced the closing of its previously announced prospectus offering of convertible debentures. The financing saw

Gatekeeper Systems To Install Tech In 170 Buses In Alberta
Briefing News Technology 

Gatekeeper Systems To Install Tech In 170 Buses In Alberta

May 18, 2022 10:51 AM Jay Lutz 0
AmmPower Produces First Ammonia From Demonstration Unit
Briefing Industrials News 

AmmPower Produces First Ammonia From Demonstration Unit

May 18, 2022 8:57 AM Jay Lutz 0
Arctic Star Sees Diamond Analysis Point To 50% Being Nitrogen Free Type IIa Diamonds
Briefing News Resources 

Arctic Star Sees Diamond Analysis Point To 50% Being Nitrogen Free Type IIa Diamonds

May 17, 2022 3:21 PM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Psychedelics
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2022 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.